British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation at its ...

Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation due to ...

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field ...

We recently published a list of 11 Best Innovative Stocks to Buy According to Analysts. In this article, we are going to take ...

GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Just hours after thousands of U.S. Food and Drug Administration employees were shown the door, Barclay Butler, the agency’s ...

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.